Adverse Reactions to Immunotherapy Can Appear After a Year
Clinicians should be on the lookout for immune-related adverse reactions (irAEs) even after patients have been receiving anti–programmed cell death […]
» Read moreHome »
An experimental immunotherapy that contains a genetically altered version of herpes simplex virus type 1 (HSV-1) was associated with a […] Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Last year, cancer screening programs around […] Liver transplant might be the next big thing for extensive hepatic metastases in colorectal cancer, according to an editorial published […] NEW YORK (Reuters Health) – Caution may be required when using anticancer drugs targeting angiogenesis because of the potential risk […] Working night shifts has been associated with an increased risk for certain cancers, as well as other health disorders. Indeed, […] A treatment previously shown to clear the precancerous skin lesions called actinic keratosis now appears to reduce the chance that […] MONDAY, Oct. 1, 2018 — Libtayo (cemiplimab-rwlc) injection has been approved by the U.S. Food and Drug Administration to treat […]
Deadly Brain Tumor: Survival Extended by Oncolytic Virus Product
Cancer Screening Stopped by Pandemic: Repercussions to Come?
Liver Transplant Emerges for Hepatic Mets in Colorectal Cancer
Antiangiogenic Agents for Cancer May Boost Aneurysm Risk
Increased Cancer Risk From Night Shift Due to Gene Dysregulation?
Immunotherapy of precancerous skin lesions may prevent squamous cell carcinoma
FDA Approves New Treatment for Squamous Cell Carcinoma
